Cited by 510Cancer survivorship and careHealth Systems, Economic Evaluations, Quality of LifePain Management and Opioid Use

The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO clinical practice guideline

Open access
Di Maio, M., Basch, E., Denis, F., Fallowfield, L.J., Ganz, P.A., Howell, D., Kowalski, C., Perrone, F. +8 more·2022·Annals of Oncology

Abstract

Patients with cancer frequently experience symptoms related to their disease or treatment-related toxicities. Symptom management through optimal supportive care is a foundation of quality care. While objective toxicities and laboratory results are amenable to reporting by health care personnel, subjective experiences such as symptoms are best reported by patients themselves.1 Traditionally, patients are relied upon to discuss symptoms and side-effects with the clinical team during hospital and clinic visits, when contacting their health care team between visits via telephone or, more recently, electronic messaging.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.annonc.2022.04.007

Cites

108 of 108 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Coombes RC, Bliss J, Hall E, et al. Under-reporting of symptoms in patients with early breast cancer who have received tamoxifen treatment for 2e3 years. Proc Am Soc Clin Oncol. 2003;22:48.
  2. Breen S, Aranda S, Ritchie D, et al. Improving the management of chemotherapy toxicities in haematological cancer patients: a phase II randomised controlled trial of the Patient Remote Intervention and Symptom Management System (PRISMS). Asia Pac J Clin Oncol. 2012;8:312.

Cited by

Sorted by citations

Authors
Di Maio, M., Basch, E., Denis, F., Fallowfield, L. J., Ganz, P. A., Howell, D., Kowalski, C., Perrone, F., Stover, A. M., Sundaresan, P., Warrington, L., Zhang, L., Apostolidis, K., Freeman-Daily, J., Ripamonti, C. I., & Santini, D.
Affiliations
  • University of North Carolina at Chapel Hill (US)
  • Université Paris Cité (FR)
  • Brighton and Sussex Medical School (GB)
  • University of California, Los Angeles (US)
  • Princess Margaret Cancer Centre (CA)
  • German Cancer Society (DE)
  • Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT)
  • The University of Sydney (AU)
  • University of Leeds (GB)
  • Sun Yat-sen University Cancer Center (CN)
  • Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
  • Università Campus Bio-Medico (IT)
Venue
Annals of Oncology
Publisher
Elsevier BV
Published
2022-09
Volume
33
Issue
9
Pages
878-892
ISSN
0923-7534 (ISSN-L)
OpenAlex
W4224250553
Cited by
509
References
108
Citations by year
2026: 126 · 2025: 129 · 2024: 149 · 2023: 88 · 2022: 17
FWCI
40.18
Type
journal article
Language
en
Open access
Locations
  • Annals of Oncology (publishedVersion, other-oa)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, other-oa)
  • Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
  • Sussex Research Online (University of Sussex) (submittedVersion, cc-by-nc-nd)
  • Figshare (submittedVersion, cc-by-nc-nd)
Funders
  • Breast Cancer Research Foundation
  • LUNGevity Foundation
  • Eli Lilly and Company
  • Pfizer
  • AstraZeneca
  • GlaxoSmithKline
  • Sanofi
  • Leukemia and Lymphoma Society
  • International Association for the Study of Lung Cancer
  • Patient-Centered Outcomes Research Institute
  • American Society of Clinical Oncology
  • Associazione Italiana di Oncologia Medica
  • Bladder Cancer Advocacy Network
  • Exelixis
  • Les Laboratories Pierre Fabre
  • BeiGene
  • Incyte
  • Association of Community Cancer Centers
  • Veracyte
  • UroGen Pharma
  • York University
  • University of Oxford
  • Cancer Australia
  • Astellas Pharma
  • Angelini Pharma
  • European Society for Medical Oncology
  • Ipsen
  • National Institutes of Health
  • Agency for Healthcare Research and Quality
  • Genentech
  • Chugai Pharmaceutical
  • National Cancer Institute
Topics
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
Keywords
patient-reported outcome measures, cancer symptoms, supportive care, symptom management, treatment toxicity, patient-reported symptoms, quality of life
MeSH terms
Patient Reported Outcome Measures, Humans, Neoplasms, Surveys and Questionnaires

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review